Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Path to New Therapies for Schizophrenia and Bipolar Illness.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Apr 2017

Scolnick Edward M

Abstract excerpt

Schizophrenia and bipolar illness are two of the most serious forms of mental illness. Until relatively recently, almost nothing was known about the molecular pathogenesis of either illness. The single largest risk factor that predisposes people to schizophrenia or bipolar illness is genetic risk. Heritability is high, and the incidence is significantly higher in identical twins than in nonidentical twins....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Molecular Targeted Therapy

Share to Schizophrenia

Source

Identifiers

PMID: 28360375
DOI: 10.1096/fj.201700028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Path to New Therapies for Schizophrenia and Bipolar Illness.PMID 28360375Read ↗

Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.Semantic proximity Read ↗

A shared pathway connects schizophrenia and bipolar disorder.Semantic proximity Read ↗

Precision psychiatry - a feasible possibility?Semantic proximity Read ↗

Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?Semantic proximity Read ↗

[Approach for identifying novel drug targets of schizophrenia].Semantic proximity Read ↗

Potentially repurposable drugs for schizophrenia identified from its interactomeSemantic proximity Read ↗

[Epidemiology and natural history of schizophrenia].Semantic proximity Read ↗

[Translational research for mental disorder -schizophrenia].Semantic proximity Read ↗

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.Semantic proximity Read ↗

[Preventive treatments in schizophrenia].Semantic proximity Read ↗

Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.Semantic proximity Read ↗

[Prospects for retroelement-targeted therapy of schizophrenia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.